Not evaluated by SAHPRA. Research & educational information only — nothing is for sale; not intended to diagnose, treat, cure or prevent any disease.

PerformanceResearch vialGH secretagogueGHRH analogblendrecoveryfat loss

CJC-1295 + Ipamorelin

Synergistic GH pulse for recovery and fat loss

Format: Research vial
Strength / pack: 10mg vial
Category: Performance

Synergistic GH releaseGHRH analog plus ghrelin-receptor agonist hit two pathways at once for a larger pulse than either component alone.

Pulsatile, not flatlinedThe non-DAC version of CJC-1295 has a half-life of minutes, producing a profile closer to native GH secretion than long-acting variants.

Clean side-effect profileIpamorelin is the GH-selective component — no ACTH, cortisol, prolactin or TSH spike at research doses.

Recovery and body compositionSupports the GH / IGF-1 axis used in research for fat loss, lean-mass retention and post-training recovery.

A two-peptide blend pairing a GHRH analog (CJC-1295) with a selective GHS-R / ghrelin-receptor agonist (Ipamorelin). CJC-1295 raises the baseline of pulsatile GH release through the GHRH receptor; Ipamorelin amplifies pulse amplitude through the ghrelin receptor without driving cortisol, prolactin or ACTH. Most "CJC + Ipa" research blends use **CJC-1295 without DAC** (Modified GRF 1-29), which has a short half-life of minutes and produces a pulsatile profile closer to native GH secretion than the long-acting DAC version.

Related research

PerformanceResearch vial

5mg vial

Ipamorelin

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and a selective agonist of the growth-hormone-secretagogue receptor (GHS-R1a) — the same receptor targeted by ghrelin. It triggers pulsatile GH release without the ACTH, cortisol and prolactin spikes seen with older GHRPs (GHRP-2, GHRP-6, hexarelin).

Read the research →

PerformanceResearch vial

5mg vial

Hexarelin

Hexarelin is a synthetic hexapeptide analog of GHRP-6 and a potent agonist of the growth-hormone-secretagogue receptor (GHS-R1a). It also binds the non-GHS-R receptor CD36, which underlies a separate cardiac action that does not depend on GH release. Of the older GHRPs it produces the strongest GH pulse.

Read the research →

PerformanceResearch vial

1mg vial

IGF-1 LR3

IGF-1 LR3 (Long R3 IGF-1) is an 83-amino-acid synthetic analog of insulin-like growth factor 1 with a 13-residue N-terminal extension and an arginine substituted for glutamic acid at position 3. The Arg-3 substitution drops affinity for IGF binding proteins ~100-fold while preserving full IGF-1 receptor agonism, so more of the injected peptide is free to bind tissue.

Read the research →

Publisher

Elegant Slimming · Mokopane, Limpopo, South Africa

Research library · nothing on this site is for sale.

Regulatory

This compound has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).

For information purposes only — not intended to diagnose, treat, cure or prevent any disease.